Stroke Clinical Trials

Find Stroke Clinical Trials Near You

The Akershus Study of Ischemic Stroke and Thrombolysis -1 (ASIST-1) Epidemiology, Clinical and Radiological Presentation and Treatment of Cerebrovascular Disease and Stroke Mimics in a Norwegian Population

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This observational study comprises consecutively patients with cerebrovascular diseases admitted to the Stroke Unit at Akershus University Hospital in Norway. Akershus University Hospital is the largest emergency care hospital in Norway and has a catchment area covering a population of 550.000, which is approximately 10 % of the Norwegian population and reasonably representative according to data from Statistics Norway. The hospital is public and serving both as a primary hospital and a university hospital. Due to the Norwegian, national, all-covering health-insurance, all patients enter the hospital and are considered for further in-patient care on the same conditions. The hospital has a stroke unit classified as a comprehensive stroke center according to European Stroke Organisation standards. Acute stroke management follows national and international guidelines. Overall, the ASIST-1 study will investigate management, outcome and prognosis of stroke and stroke care pathways and later follow up in primary care using several approaches combining existing clinical data from a representative population with different Norwegian health registries. Parts of the study are retrospective with prospective follow-up by health registries and parts of the study are prospective.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Cerebrovascular diseases (acute ischemic stroke, intracerebral hemorrhage, transient ischemic attack) or stroke mimics

Locations
Other Locations
Norway
Akershus University Hospital
RECRUITING
Lørenskog
Contact Information
Primary
Espen S. Kristoffersen, MD, PhD
e.s.kristoffersen@medisin.uio.no
Time Frame
Start Date: 2012-01-01
Estimated Completion Date: 2040-12-31
Participants
Target number of participants: 6000
Treatments
Intravenous thrombolysis (IVT)
All patients treated with IVT in the acute stroke care pathway 2012-2025
Intracerebral hemorrhage (ICH)
All patients with intracerebral hemorrhage 2012-2019
Acute ischemic stroke (AIS) and Intracerebral hemorrhage (ICH)
All patients with acute ischemic stroke or intracerebral hemorrhage 2015-2017
Stoke care pathway
All patients admitted to the stroke care pathway (ischemic stroke, intracerebral hemorrhage, transient ischemic attack and stroke mimics) 2015-2017
Endovascular treatment
All stroke patients treated with endovascular treatment 2012-2025
Cerebellar hematoma (cICH)
All patients with cerebellar hematoma 2008-2019
Related Therapeutic Areas
Sponsors
Collaborators: University of Oslo, Oslo University Hospital
Leads: University Hospital, Akershus

This content was sourced from clinicaltrials.gov